Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence
Recruiting in Palo Alto (17 mi)
+4 other locations
Age: 18+
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Sciton
No Placebo Group
Trial Summary
What is the purpose of this trial?This multi-center clinical trial will evaluate the safety and long-term efficacy of hybrid fractional 2940 nm and 1470 lasers for improvement of symptoms of urinary incontinence.
Eligibility Criteria
Inclusion Criteria
Healthy biological female aged between 30 to 75 years
Is experiencing at least one or a combination of the following symptoms of urinary incontinence (UI)
involuntary urine leakage on effort, exertion, sneezing, coughing
+6 more
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Hybrid Fractional LaserExperimental Treatment1 Intervention
Hybrid fractional 2940 nm and 1470 nm laser treatment
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Carolinas Healthcare SystemCharlotte, NC
Woodlands Gynecology & AestheticsThe Woodlands, TX
Women's Pelvic Health InstituteLos Gatos, CA
The Female Pelvic Medicine Institute of VirginiaNorth Chesterfield, VA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
ScitonLead Sponsor